PET/CT Follow up for Head and Neck Squamous Cell Carcinoma
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
PET/CT follow up for Head and Neck Squamous Cell Carcinoma The following is a presentation of a prospective protocol, named PET/CT follow up for Head and Neck Squamous Cell Carcinoma (PET Follow), including patients who have completed radiotherapy treatment for squamous cell carcinoma of the head and neck (HNSCC). The purpose of this study is to investigate the diagnostic performance of 18F-fluorodeoxy-D-glucose (FDG) Positron Emission Tomography/ Computed Tomography (PET/CT) in patients with HNSCC after curative intended treatment.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Świadoma zgoda na uczestnictwo w badaniu
- •Wiek powyżej 18 lat
- •Ukończone leczenie (radioterapia) raka płaskonabłonkowego głowy, gardła lub krtani
✗ Disqualifies
- •Odmowa uczestnictwa w badaniu
- •Pacjenci bez zmian rakalnych w węzłach chłonnych szyi
- •Pacjenci, którzy przeszli operacyjne usunięcie węzłów szyi przed radioterapią
- •Pacjenci niezdolni do operacji z jakiegokolwiek powodu
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 12, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Department of Otorhinolaryngology, Head & Neck Surgery and Audiology, Rigshospitalet
Copenhagen, Denmark
Trial contact
Jacob H Rasmussen, MD; PhD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/13/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.